This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Neurology  • Cerebrovascular Disease  • Stroke  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Hypertension  • Alert me on articles by topic  Social Bookmarking   What's this?

Jan A. Staessen, MD, PhD; Tatiana Kuznetsova, MD; Katarzyna Stolarz, MD

JAMA. 2003;289:2420-2422.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Blood pressure (BP) is the most consistent and powerful predictor of stroke, such that hypertension is causally involved in nearly 70% of all stroke cases.¹ Worldwide, stroke is second only to ischemic heart disease as a leading cause of death.² In a quantitative overview of 61 cohort studies with more than 1 million enrolled subjects,³ the Prospective Studies Collaboration demonstrated that small gradients in systolic or diastolic BP account for sizable differences in cardiovascular outcomes. Along similar lines, several recently published outcome trials in hypertensive patients or patients at high cardiovascular risk proved that reductions in systolic BP as small as 1 to 3 mm Hg decrease the relative risk of stroke by as much as 20% to 30%.⁴

Despite the consistency of findings among observational cohort studies³ and outcome trials in hypertension,⁴ the geographic heterogeneity in the patterns . . . [Full Text of this Article]

Author Affiliations: Study Coordinating Centre, Hypertension Unit, Department of Molecular and Cardiovascular Research, University of Leuven, Leuven, Belgium.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States
Katharina Wolf-Maier, Richard S. Cooper, José R. Banegas, Simona Giampaoli, Hans-Werner Hense, Michel Joffres, Mika Kastarinen, Neil Poulter, Paola Primatesta, Fernando Rodríguez-Artalejo, Birgitta Stegmayr, Michael Thamm, Jaakko Tuomilehto, Diego Vanuzzo, and Fenicia Vescio
JAMA. 2003;289(18):2363-2369.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Understanding the Experience of Stroke: A Mixed-Method Research Agenda
Clarke
The Gerontologist 2009;49:293-302.
ABSTRACT | FULL TEXT  

Foundational Ethics of the Health Care System: The Moral and Practical Superiority of Free Market Reforms
Sade
J Med Philos 2008;33:461-497.
ABSTRACT | FULL TEXT  

Differences in Blood Pressure Control and Stroke Mortality Across Spain: The Prevencion de Riesgo de Ictus (PREV-ICTUS) Study
Redon et al.
Hypertension 2007;49:799-805.
ABSTRACT | FULL TEXT  

Toward Targeted Hypertension Screening Guidelines
van Buuren et al.
Med Decis Making 2006;26:145-153.
ABSTRACT